The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life, according to a new ...

Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

The right medicine for you depends on your symptoms, other medications you take, and how severe your anxiety or depression is. Antianxiety Medications Often, healthcare providers select a medication ...

Experts say the drugs are safe and effective. Shortly after Robert F. Kennedy Jr. was sworn in as secretary of the Department of Health and Human Services, President Donald Trump issued an ...